Narjust Florez
MD
Associate Director of the Cancer Care Equity Program and Assistant Professor of Medicine
Dana-Farber Cancer Institute
Harvard Medical School
Feb 14, 2023
Episode
146
Soundcloud
Share
In this episode of Lung Cancer Considered, host Dr. Narjust Florez leads a discussion about NSCLC with RET rearrangements, including diagnosis, treatment, and new exciting research coming down the pipeline.
Dr. Justin Gainor, the Director of the Center for Thoracic Cancers at the Massachusetts General Hospital (MGH), Director of Targeted Immunotherapy in the Henri and Belinda Termeer Center for Targeted Therapies, and Co-Leader of the SU2C Lung Cancer Dream Team. His major research interests have focused on targeted therapy and immunotherapy.
Dr. Lizza Hendricks, Assistant Professor at research institute GROW, School for Oncology and Developmental Biology of Maastricht University in the Netherlands. Her focus area is thoracic oncology, in particular, prevention and optimal treatment of brain metastases in lung cancer and targeted therapy. Since 2019, Dr. Hendriks has coordinated the clinical lung cancer research of the lung diseases department in Maastricht.
Guest
Lizza Hendriks
MD, PhD
Assistant Professor
Research Institute GROW, School for Oncology and Developmental Biology of Maastricht University
Justin F. Gainor
MD
Director of the Center for Thoracic Cancers
Massachusetts General Hospital (MGH)
